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Abstract 
The majority of common risk alleles identified for neuropsychiatric disorders reside in non-coding 
regions of the genome and are therefore likely to impact gene regulation. However, the genes that 
are primarily affected and the nature and developmental timing of these effects remain unclear. 
Given the hypothesised role for early neurodevelopmental processes in these conditions, we here 
define genetic predictors of gene expression in the human fetal brain with which we perform 
transcriptome-wide association studies (TWASs) of attention deficit hyperactivity disorder (ADHD), 
autism spectrum disorder, bipolar disorder, major depressive disorder and schizophrenia. We 
identify prenatal cis-regulatory effects on 63 genes and 166 individual transcripts associated with 
genetic risk for these conditions. We observe pleiotropic effects of expression predictors for a 
number of genes and transcripts, including those of decreased DDHD2 expression in association with 
risk for schizophrenia and bipolar disorder, increased expression of a ST3GAL3 transcript with risk for 
schizophrenia and ADHD, and increased expression of an XPNPEP3 transcript with risk for 
schizophrenia, bipolar disorder and major depression. For the protocadherin alpha cluster genes 
PCDHA7 and PCDHA8, we find that predictors of low expression are associated with risk for major 
depressive disorder while those of higher expression are associated with risk for schizophrenia. Our 
findings support a role for altered gene regulation in the prenatal brain in susceptibility to various 
neuropsychiatric disorders and prioritize potential risk genes for further neurobiological 
investigation.  
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Introduction 
Genome-wide association studies (GWAS) have successfully identified hundreds of high-confidence 
genetic risk loci for neuropsychiatric disorders 1-5. However, the DNA variants exhibiting strongest 
evidence for association with these conditions are typically in non-coding sequence, making it 
difficult to predict the actual susceptibility genes. One possible solution is to use expression 
quantitative trait loci (eQTL) maps in relevant human tissues to determine whether identified risk 
variants are associated with altered expression of specific genes at these loci e.g. 6. An alternative 
approach is to first define the DNA variants associated with the cis-component of a gene’s 
expression in a given tissue, and then use these to predict the relative expression of that gene in 
cases and controls from a much larger GWAS dataset 7, 8. This latter design, known as a 
transcriptome-wide association study (TWAS), recognizes that a gene might be regulated by multiple 
cis-acting variants, involves a smaller number of independent tests than a typical GWAS, and allows 
direct interpretation of risk in terms of the potentially pathogenic mechanism of gene expression.   
 
Prenatal brain development is hypothesised to be an important window of vulnerability for several 
neuropsychiatric disorders 9, 10, implying that regulatory effects of risk alleles might operate during 
this period.  Indeed, common genetic risk variants for these conditions have been found to be 
enriched within epigenomic annotations indicative of active regulatory genomic sites in the fetal 
brain 11, 12.  Moreover, we have recently mapped eQTL operating in the human brain during the 
second trimester of gestation, showing these to be enriched among common risk variants for various 
neuropsychiatric disorders, and providing the means to link risk alleles with gene expression in the 
prenatal brain 13.  Here, we combine data from that study with large-scale GWAS data for 
neuropsychiatric disorders to identify, through TWAS, genes and individual transcripts where 
heritable cis-effects on their expression in the human fetal brain are associated with risk for 
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attention deficit hyperactivity disorder (ADHD), autism spectrum disorder (ASD), bipolar disorder, 
major depressive disorder and schizophrenia.  
 
Methods 
Datasets 
Predictors of cis-regulated gene expression were derived from whole transcriptome RNA sequencing 
and genome-wide genotyping of brain tissue from 120 human fetuses aged 12 -19 post-conception 
weeks (for a full description of samples and data generation, see reference 13). We performed TWAS 
using genome-wide association summary statistics from recent large-scale studies of schizophrenia 
(40,675 cases, 64,643 controls) 1, major depressive disorder (135,458 cases, 344,901 controls) 2, 
ADHD (20,183 cases, 35,191 controls) 3, ASD (18,381 cases, 27,969 controls) 4 and bipolar disorder 
(20,352 cases and 31,358 controls) 5.  
 
TWAS analysis using FUSION 
Single nucleotide polymorphism (SNP)-weight predictors of Ensembl gene and transcript level cis-
expression were generated from fetal brain RNA sequencing and genotype data using the FUSION 
pipeline (http://gusevlab.org/projects/fusion/). We restricted our analyses to genes and transcripts 
with significant evidence of cis-heritable expression at the default P-value (P < 0.01) in FUSION.  
GWAS summary statistics were prepared for use in FUSION using the munge_sumstats.py script in 
LD Score Regression (https://github.com/bulik/ldsc). The extended MHC region (GRCh37/hg19 
coordinates chr6:28,477,797 - 33,448,354) was removed prior to analysis to avoid spurious 
associations driven by the linkage disequilibrium pattern in this region. TWAS was performed on 
autosomal chromosomes using the FUSION.assoc.test.R script with default parameters. A multiple-
testing correction was applied to TWAS P-values using the Bonferroni method within each 
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phenotype. To compare our TWAS findings with GWAS risk loci, implicated genes and transcripts 
were mapped in relation to the genomic coordinates of the genome-wide significant loci from their 
corresponding GWAS (12 loci in ADHD 3, 5 loci in ASD 4, 30 loci in bipolar disorder 5, 44 loci in major 
depressive disorder 2, and 145 loci in schizophrenia 1). 
 
Conditional Analysis 
Genes and transcripts achieving TWAS-wide significance (Bonferroni-corrected P < 0.05) for each 
disorder were assigned to loci using a +/-250kb window. Loci containing multiple implicated genes / 
transcripts were subjected to conditional analysis, implemented by the FUSION.post_process.R 
script, to determine statistically independent signals. 
 
Data availability 
The SNP weights for predictors of fetal brain gene- and transcript- level expression that were 
generated and analysed in the current study are available in a Figshare repository 
(https://doi.org/10.6084/m9.figshare.11637036). Individual RNA-Seq FASTQ files are available 
through the European Genome-phenome Archive (https://ega-archive.org) under study accession 
EGAS00001003214. 
 
Results 
Using FUSION software, we identified 1351 genes and 3985 individual Ensembl transcripts displaying 
significant cis-heritable expression (P < 0.01) in our reference panel of 120 fetal brains. We then 
determined genetic predictors of the cis-component of each gene / transcript’s expression within 
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the reference panel and used these to impute the cis-genetic component of gene expression into 
GWAS summary data for five major neuropsychiatric disorders 1-5.   
 
We identified 32 genes and 103 individual transcripts for which genetic cis-effects on fetal brain 
expression are associated with schizophrenia at a Bonferroni-corrected P < 0.05 (Supplementary 
Tables 1 and 2). Eleven of these genes and 34 of these transcripts are located within 16 of the 145 
schizophrenia-associated loci identified in the corresponding GWAS 1; a further 21 genes and 69 
transcripts reside outside of these regions and were therefore not previously implicated. We 
excluded the major histocompatibility complex (MHC) on chromosome 6 from our analyses due to 
extensive linkage disequilibrium in the region, but note that we have previously implicated 
expression of C4A (as well as that of other genes at the MHC locus) in risk for schizophrenia in our 
previous analysis of these fetal brain gene expression data using summary data-based Mendelian 
randomization 13. Of genes outside of the MHC region, most significant association was observed for 
predictors of increased expression of SMDT1 (P corrected = 4.31 X 10-7), encoding a mitochondrial 
calcium channel subunit. This association has not, to our knowledge, been reported in any 
schizophrenia TWAS performed using expression predictors from adult brain tissue and may 
therefore indicate a fetal-specific risk mechanism. Of the other 31 genes that we implicate in 
schizophrenia at Bonferroni-corrected significance, 20 are significantly associated with schizophrenia 
with the same direction of effect based on expression predictors from adult cerebral cortex 14 
(Supplementary Table 1). These include increased expression of AS3MT, encoding arsenite 
methyltransferase (this study: P corrected = 7.55 X 10-7; Gandal et al 2018 study: P corrected = 0.0001), 
consistent with previous findings in adult and fetal brain using measures of allele-specific expression 
15. Of the 24 genes that we implicate that also have HUGO Gene Nomenclature Committee (HGNC) 
symbols, 6 (SMDT1, WBP2NL, CSPG4P11, DDHD2, PCDHA2 and ARL14EP) are also reported to be 
differentially cis-regulated in association with schizophrenia genetic risk in a recent TWAS using a 
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distinct collection of human fetal brain samples 16, and all with the same direction of effect. We also 
note association with expression predictors for transcripts of genes that have been implicated in 
schizophrenia through splicing QTL in the adult 17, 18 or fetal brain 16, including transcripts of APOPT1 
(P corrected = 1.52 X 10-9), SDCCAG8 (P corrected = 4.6 X 10-8) and GNL3 (P corrected = 1.02 X 10-5). 
 
ADHD was found to be associated with fetal brain expression predictors for 3 genes and 4 individual 
transcripts at a Bonferroni-corrected P < 0.05 (Supplementary Tables 3 and 4). Only one of these 
genes (ST3GAL3; see below) resides within any of the 12 risk loci identified by the corresponding 
GWAS 3. The strongest association at the gene level was with reduced expression of COL28A1 (P 
corrected = 0.012), encoding a collagen that is predominantly expressed in developing neural tissue 19. 
Consistent with this being a primarily early neurodevelopmental risk mechanism, a previous TWAS of 
ADHD using expression predictors from multiple adult brain regions found only nominally significant 
evidence for association with COL28A1 expression in two brain areas (amygdala and cerebellum; 
Supplementary Table 3) 20. The most significant association we observed for ADHD was with 
increased expression of a transcript of ST3GAL3 (P corrected = 1.19 X 10-9), a gene linked to intellectual 
disability 21 which has been reported to be differentially methylated at birth in association with later 
ADHD symptomatology 22. The ST3GAL3 gene has previously been implicated in ADHD through a 
TWAS analysis combining results across multiple adult brain regions 20.  The second most significant 
association with ADHD we observed was for predictors of increased expression of a transcript of the 
tyrosine kinase TIE1 (P corrected 0.0047), again supported by TWAS in adult brain, where association 
between ADHD and predictors of higher TIE1 expression in adult dorsolateral prefrontal cortex was 
reported 20.  
 
We identified 17 genes and 29 transcripts for which predictors of cis-heritable expression in fetal 
brain were associated with ASD at a Bonferroni-corrected P < 0.05 (Supplementary Tables 5 and 6). 
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None of these genes or transcripts reside within the 5 loci exhibiting genome-wide significant 
association with ASD in the corresponding GWAS 4. Consistent with our previous TWAS of ASD using 
expression weights derived from a subset of the present samples 23 and a recent TWAS using 
predictors derived from adult cerebral cortex 14, the majority of implicated genes are located within 
a common polymorphic inversion on chromosome 17q21, which is associated with differential cis-
regulation of numerous genes in the fetal brain 13 . The gene within this inversion for which 
expression predictors from the adult brain showed strongest association with ASD is LRRC37A 
(supplementary Table 5), encoding a leucine-rich repeat-containing protein. Expression of LRRC37A 
in the fetal brain has also been implicated in intracranial volume 16 and the personality trait of 
neuroticism 13. The only association with ASD we observed outside of this inversion was with 
decreased expression of a transcript of TM2D2 (P corrected = 0.038), a protein-encoding gene of 
unknown function. 
 
Bipolar disorder was found to be associated with fetal brain expression predictors for 8 genes and 19 
transcripts at a Bonferroni-corrected P < 0.05 (Supplementary Tables 7 and 8). Five of these genes 
and 13 of these transcripts are located within 4 of the 30 loci associated with bipolar disorder in the 
corresponding GWAS 5; a further 3 genes and 6 transcripts reside outside of these loci and therefore 
represent novel associations. Implicated protein-coding genes include NMB, encoding neuromedin B 
(P corrected = 0.0002), LRRC57, encoding Leucine Rich Repeat Containing 57 (P corrected = 0.001) and 
DDHD2 (P corrected = 0.013), encoding DDHD Domain Containing 2. NMB and LRRC57 also show 
significant association with bipolar disorder in a previous TWAS based on expression predictors from 
adult cerebral cortex 14 (Supplementary Table 7); however, the association with NMB is in the 
opposite direction (i.e. increased, rather than decreased, expression in adult brain in association 
with risk for bipolar disorder), and neither observation is transcriptome-wide significant. The 
association between reduced DDHD2 expression and bipolar disorder has previously been reported 
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based on gene expression predictors from the adult dorsolateral prefrontal cortex, cerebellum, 
pituitary and caudate 24.  Our most significant observation in fetal brain for bipolar disorder was for 
predictors of increased expression of a transcript of PACS1 (P corrected = 3.8 X 10-5), encoding 
Phosphofurin Acidic Cluster Sorting Protein 1, a gene in which rare mutations cause intellectual 
disability 25. Predictors of increased expression of PACS1 are also associated with bipolar disorder at 
the whole gene level in the adult cerebral cortex (P = 0.000653) 14, although this was not highlighted 
in that study as it did not survive Bonferroni correction.  
 
We identified 3 genes and 11 individual transcripts with expression predictors associated with major 
depressive disorder at a Bonferroni-corrected P < 0.05 (Supplementary Tables 9 and 10). One of 
these genes and 7 transcripts map to 7 of the 44 independent genome-wide significant loci identified 
by the corresponding GWAS 2. Most significant association at the gene level was with predictors of 
decreased expression of IMMP1L, encoding a mitochondrial protein (P corrected = 5.45 X 10-5). We also 
observed association between depression and predictors of decreased expression of PCDHA7 and 
PCDHA8 (P corrected = 0.048 and 0.011, respectively), encoding members of the protocadherin alpha 
cluster, which has been implicated in the formation and maintenance of complex neural circuits 26. 
None of these genes were highlighted in a previous TWAS of major depressive disorder based on 
expression predictors from adult prefrontal cortex 2.  However, that previous study 2 did implicate 
adult brain expression of 3 genes in risk for major depressive disorder that we also find to be 
associated with the condition based on transcript-specific measures in the fetal brain; namely, 
DENND1B (this study P corrected = 0.0004), XPNPEP3 (this study P corrected = 0.004) and DLST (this study P 
corrected = 0.014). 
 
For loci that contained, within a 500kb window, more than one gene or transcript implicated in each 
disorder, we performed conditional analyses to identify independent associations (Supplementary 
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table 11). In interpreting these data, we note that effects on genes / transcripts that are 
conditionally non-significant do not necessarily imply that they are unrelated to risk for these 
disorders, only that these effects are not independent of more significant effects on other genes / 
transcripts at these loci. However, for schizophrenia, we were able discern conditionally 
independent associations with transcripts of MRM2 and SNX8 at a locus on chromosome 7, 
transcripts of C12ORF65, RSRC2 and KNTC1 on chromosome 12, and the SMDT1 and WBP2NL genes 
on chromosome 22. Schizophrenia was also associated with independent effects on alternative 
transcripts of ST3GAL3, SDCCAG8, NCK1-DT and MARK3, while bipolar disorder was associated with 
independent effects on GOLGA2P7 and a transcript of UBE2Q2P1 on chromosome 15, and 
transcripts of CDK10 and CHMP1A at a locus on chromosome 16. 
 
Cis-heritable effects on the expression of 8 genes and 13 transcripts were significantly associated 
with more than one neuropsychiatric condition (Fig. 1 and Fig. 2). For example, increased expression 
of the previously highlighted ST3GAL3 transcript ENST00000489897 was associated with 
schizophrenia (P corrected = 0.013) as well as ADHD (P corrected = 1.19 X 10-9), while predictors of 
decreased expression of the NMB gene were associated with both schizophrenia (P corrected = 0.002) 
and bipolar disorder (P corrected = 0.0002). Predictors of increased expression of a transcript of 
XPNPEP3, encoding X-Prolyl Aminopeptidase 3, were significantly associated with major depressive 
disorder (P corrected = 0.0043), bipolar disorder (P corrected = 0.0006), and schizophrenia (P corrected = 
0.0023). Although only surviving Bonferroni correction for schizophrenia (P corrected = 2.7 X 10-5) and 
bipolar disorder (P corrected = 0.013), predictors of reduced expression of DDHD2, a brain triglyceride 
hydrolase associated with hereditary spastic paraplegia and intellectual disability 27, were 
significantly (P < 0.05) associated with all 5 tested neuropsychiatric conditions. Intriguingly, while 
predictors of low expression of the protocadherin genes PCDHA7 and PCDHA8 were associated with 
major depressive disorder (P corrected = 0.048 and 0.011, respectively), predictors of higher expression 
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of these genes were associated with schizophrenia (P corrected = 0.019 and 0.0004, respectively). These 
genes reside at a locus on chromosome 5 where opposing effects on risk for schizophrenia and 
major depressive disorder have recently been reported 28. 
Please insert Figures 1 and 2 around here 
 
Discussion  
An essential first step in translating GWAS findings into an understanding of molecular risk 
mechanisms for neuropsychiatric disorders is to elucidate the genes that are primarily affected, how 
they are functionally impacted and when (and where) these effects take place 29. We have here 
applied TWAS methodology to genome-wide association summary statistics for 5 major 
neuropsychiatric disorders in order to identify genes that are differentially cis-regulated in the 
human second trimester fetal brain in association with genetic risk variation for these conditions. 
Our findings are consistent with the hypothesis that altered gene expression in the prenatal brain 
plays a role in the later development of neuropsychiatric disorders and nominate genes and 
individual gene transcripts for further neurobiological investigation.  
 
While previous TWAS of neuropsychiatric disorders have largely focused on individual diagnoses 
using gene expression predictors derived from the adult brain e.g. 18, 20, we have here performed 
TWAS on multiple neuropsychiatric conditions, based on gene expression in the fetal brain. This 
allowed us to identify genetic risk-associated differences in prenatal gene expression that are unique 
to, or shared by, neuropsychiatric diagnoses. Our finding of numerous prenatal gene expression 
differences associated with genetic risk for schizophrenia is consistent with the long-hypothesised 
early neurodevelopmental component to this condition 9, 30.  Although bipolar disorder is generally 
considered to be less neurodevelopmental in origin, we identified prenatal cis-regulatory effects on 
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a number of genes and transcripts associated with genetic risk for the condition, consistent with our 
previous finding that fetal brain eQTL are enriched within genetic risk variants for bipolar disorder as 
well as schizophrenia and ADHD 13. Moreover, we observed multiple instances where schizophrenia-
associated cis-effects on prenatal gene expression were shared with bipolar disorder, consistent 
with the high genetic correlation between the two conditions 31. Apparent pleiotropic effects of 
prenatal cis-regulatory variation were also observed for schizophrenia and ADHD (affecting a 
transcript of ST3GAL3) and for schizophrenia, bipolar disorder and major depression (affecting a 
transcript of XPNPEP3). In the case of the protocadherin alpha cluster genes PCDHA7 and PCDHA8, 
we observed significant opposing effects on their expression in fetal brain associated with genetic 
risk for schizophrenia and major depressive disorder. These findings may prove particularly 
important given recent evidence of intrinsic abnormalities in the expression of protocadherin alpha 
cluster genes in induced pluripotent stem cell-derived neurons from patients with these disorders 32, 
33. 
 
Our comparisons with TWAS findings from adult human brain suggest that some of the gene 
expression changes that we implicate in risk for neuropsychiatric disorders are specific to brain 
development, potentially reflecting genetic risk variants residing within development-specific 
regulatory elements (e.g. enhancers) 34. However, many of the gene expression changes that we find 
to be associated with risk for neuropsychiatric disorders are also observed in adult brain, and these 
may therefore constitute ongoing risk mechanisms for these conditions. Experimental manipulations 
in model systems will be necessary to determine the relative impact of these gene expression 
changes at different developmental timepoints. 
 
Around two-thirds of the genes (46 out of 63) and transcripts (111 out of 166) that we implicate in 
neuropsychiatric disorders at Bonferroni-corrected significance are located outside of known GWAS 
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risk loci, illustrating the strength of the TWAS approach in revealing novel associations. However, a 
limitation of the current study is that, due to the modest sample size of the fetal brain gene 
expression reference panel (N = 120), we could only define genetic expression predictors for a 
fraction of genes / transcripts that are likely to be variably cis-regulated in the prenatal human brain. 
Future increases in GWAS as well as expression reference sample sizes will likely yield many 
additional associations between gene expression in the developing human brain and genetic risk for 
neuropsychiatric disorders, which could form the basis for pathway and other tests of biological 
enrichment. These might include tests of expression enrichment in specific cell types of the 
developing human brain based on single cell transcriptomic data. It should also be noted that, while 
associations between cis-regulated gene expression and genetic risk are consistent with causal 
involvement of the affected gene in the disorder, additional genetic and functional investigations 
will be required for their substantiation as risk mechanisms for these conditions. In this endeavour, 
our delineation of directional cis-regulatory effects on specific gene transcripts should provide a 
focus for investigations and guide modelling in neural systems. 
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Legends to Figures 
Figure 1. TWAS Z-scores across all 5 tested neuropsychiatric disorders for predictors of cis-
heritable gene expression that are significantly associated with at least two conditions (gene-level 
analysis). A Bonferroni corrected P < 0.05 equates to a Z-score +/- 4.12. ADHD = attention deficit 
hyperactivity disorder; ASD = autism spectrum disorder; BD = bipolar disorder; MDD = major 
depressive disorder; SCZ = schizophrenia.  
 
Figure 2. TWAS Z-scores across all 5 tested neuropsychiatric disorders for predictors of cis-
heritable gene expression that are significantly associated with at least two conditions (transcript-
level analysis). A Bonferroni corrected P < 0.05 equates to a Z-score +/- 4.36. The HUGO Gene 
Nomenclature Committee (HGNC) IDs for genes to which Ensembl transcripts are annotated are 
indicated on the left. ADHD = attention deficit hyperactivity disorder; ASD = autism spectrum 
disorder; BD = bipolar disorder; MDD = major depressive disorder; SCZ = schizophrenia. 
